Data tracker, updated 2026-06-11
UK HRT Prescribing Tracker
The NHS in England dispensed 1,056,986 HRT prescription items in June 2025, the latest month published by the NHS Business Services Authority, up 10.5 percent on the same month a year earlier. Over the last 12 published months, 12.12m HRT items were dispensed. This page tracks the official monthly figures.
1.06m
HRT items in June 2025
12.12m
items over the last 12 published months (+7.1% on the prior 12)
£18.18m
actual cost in June 2025
Monthly HRT items dispensed in England
The last 12 published months
| Month | HRT items | Actual cost |
|---|---|---|
| Jun 2025 | 1,056,986 | £18,175,059 |
| May 2025 | 1,077,138 | £18,036,211 |
| Apr 2025 | 1,000,358 | £16,777,168 |
| Mar 2025 | 1,004,333 | £17,060,186 |
| Feb 2025 | 930,504 | £15,907,869 |
| Jan 2025 | 1,029,119 | £17,612,100 |
| Dec 2024 | 987,601 | £17,575,269 |
| Nov 2024 | 978,458 | £17,533,813 |
| Oct 2024 | 1,031,149 | £18,378,517 |
| Sept 2024 | 976,725 | £17,357,809 |
| Aug 2024 | 997,702 | £17,631,382 |
| Jul 2024 | 1,051,592 | £17,284,321 |
Most prescribed HRT substances (June 2025)
| Chemical substance | Items |
|---|---|
| Estradiol | 512,173 |
| Progesterone | 258,869 |
| Estradiol with progestogen | 193,070 |
| Norethisterone | 33,897 |
| Medroxyprogesterone acetate | 23,001 |
| Tibolone | 13,872 |
| Estradiol valerate | 8,009 |
| Oestrogens conjugated | 7,061 |
How we compiled this data
Every figure on this page is computed from the NHSBSA English Prescribing Dataset, the official monthly record of what NHS primary care in England prescribes and dispenses, accessed through the OpenPrescribing.net API or the NHSBSA Open Data Portal. We sum prescription items and actual cost for every product under BNF paragraph 6.4.1 (female sex hormones and their modulators), the standard proxy for HRT prescribing. "Items" counts prescriptions dispensed, not the number of women on HRT; one woman typically receives several items a year. Figures cover England only and are published about two months in arrears. Last refreshed 2026-06-11; latest published month June 2025.
Information only, not medical advice. This tool is educational and is not a substitute for a registered clinician. It does not diagnose anything and does not recommend that you take any supplement. Always read product labels and speak to your GP or pharmacist before starting, stopping or combining supplements. Whether HRT is suitable for you, and which preparation, is a decision for you and your prescriber. The NHS menopause pages explain the options.
Read more
For what the evidence says about supplements through this life stage, see our menopause guide, the perimenopause guide and supplements for menopause. Verified UK figures are gathered on our statistics page, and our tools hub has cost calculators for the supplements we review.
Frequently asked questions
How many HRT prescriptions does the NHS issue each month?
In June 2025, the latest month published, 1,056,986 HRT prescription items (BNF paragraph 6.4.1, female sex hormones and their modulators) were dispensed in England, at an actual cost of about £18.18m. Source: NHSBSA English Prescribing Dataset.
Is HRT prescribing going up in the UK?
Yes. June 2025 items were up 10.5 percent on the same month a year earlier, and monthly volumes have risen from 0.73m in July 2022 to 1.06m in the latest month. These figures cover England only; Scotland, Wales and Northern Ireland publish separately.
Which HRT is most prescribed?
By chemical substance, the most dispensed in June 2025 were Estradiol, Progesterone, Estradiol with progestogen. Estradiol-based products dominate modern NHS prescribing. Which preparation suits an individual woman is a decision for her prescriber.
Where does this data come from?
Every figure is computed from the NHSBSA English Prescribing Dataset (the official record of what NHS primary care in England dispenses each month), accessed through the OpenPrescribing.net API or the NHSBSA Open Data Portal. We count all items under BNF paragraph 6.4.1, female sex hormones and their modulators, the standard proxy for HRT prescribing. Data is published about two months in arrears.
Source: NHSBSA English Prescribing Dataset (Open Government Licence v3.0), via OpenPrescribing.net / NHSBSA Open Data Portal, accessed 2026-06-11. This is information, not medical advice.
Editor, Her Vitals
Oliver leads Her Vitals's editorial coverage of women's life-stage health and supplements. He curates and reviews existing branded products across trying to conceive, pregnancy, postnatal, perimenopause, menopause and the senior years, weighing what the evidence supports against guidance from bodies such as EFSA, the NHS and NICE, and is clear that the content is information rather than medical advice.
Last reviewed: 11 June 2026